Trillium Health Partners, Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON M5G 1E2, Canada.
Département d'obstétrique-gynécologie, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.
The purpose of this paper is to provide evidence-based guidance on the management of a positive human papilloma virus (HPV) test and to provide guidance around screening and HPV testing for specific patient populations. The guideline was developed by a working group in collaboration with the Gynecologic Oncology Society of Canada (GOC), Society of Colposcopists of Canada (SCC), and the Canadian Partnership Against Cancer. The literature informing these guidelines was obtained through a systematic review of relevant literature by a multi-step search process led by an information specialist. The literature was reviewed up to July 2021 with manual searches of relevant national guidelines and more recent publications. The quality of the evidence and strength of recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. The intended users of this guideline include primary care providers, gynecologists, colposcopists, screening programs, and healthcare facilities. The implementation of the recommendations will ensure an optimum implementation of HPV testing with a focus on the management of positive results. Recommendations for appropriate care for underserved and marginalized groups are made.
本文旨在提供基于循证医学的人乳头瘤病毒(HPV)阳性检测管理指南,并为特定患者人群的筛查和 HPV 检测提供指导。本指南由一个工作组与加拿大妇科肿瘤学会(GOC)、加拿大阴道镜学会(SCC)和加拿大癌症伙伴关系合作制定。通过由信息专家领导的多步骤搜索过程,对相关文献进行系统综述,获得了为本指南提供信息的文献。文献综述截至 2021 年 7 月,同时对相关国家指南和最近的出版物进行了手工搜索。使用推荐评估、制定和评估(GRADE)框架对证据质量和推荐强度进行了评估。本指南的预期使用者包括初级保健提供者、妇科医生、阴道镜医生、筛查计划和医疗机构。实施这些建议将确保最佳实施 HPV 检测,重点是管理阳性结果。为服务不足和边缘化群体提供了适当护理的建议。